|
|||||
|
|
A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control |
|
| Authors: | Robert G. Moses Elizabeth Round Yue Shentu Gregory T. Golm Edward A. O'neill Ira Gantz Samuel S. Engel Keith D. Kaufman Barry J. Goldstein |
| Affiliation: | 1. Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia;2. Merck & Co., Inc, Kenilworth, New Jersey, USA |
| Abstract: | |
| Keywords: | combination therapy dipeptidyl peptidase‐4 incretins 联 合 治 疗 二 肽 基 肽 酶 肠 促 胰 素 。 |